Cramer Pamela J. bought RYTM
July 26, 2025 · Form 4 insider transaction
Cramer Pamela J. bought 3,125 shares of Rhythm Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,125
Price
N/A
Total value
N/A
InsiderCramer Pamela J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 26, 2025
Filing dateJuly 29, 2025
Shares owned after22,334
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.